Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022
The global thrombectomy devices market is estimated to reach USD 1.45 billion by 2022; growing at a CAGR of 6.7% during the forecast period. The growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are some key factors propelling the growth of this market. The factors such as increasing number of research activities in the field of thrombectomy and expanding application of ultrasound in vascular treatment are expected to offer renewed growth opportunities for market players during the forecast period.
In this report, the market has been segmented on the basis of type, application, end user, and region. Based on application, the cardiovascular segment commanded the largest share of the global thrombectomy devices market in 2016. This large market share is mainly attributed to factors such as increasing prevalence of cardiovascular diseases across major markets, procedural benefits offered by mechanical thrombectomy in cardiac surgeries, higher prevalence of thrombotic diseases among geriatric individuals, and growing preference of surgeons for image-guided and minimally invasive cardiac surgeries.
Geographically, North America is estimated to command the largest share of the global thrombectomy devices market in 2016, followed by Europe. This large market share of the North American region can be attributed to increasing adoption of technologically advanced thrombectomy products, growing number of clinical trials, and significant medical reimbursement available in the U.S. for thrombectomy procedures.
Report Coverage:
This report studies global thrombectomy devices market based on type, application, and end user. The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the thrombectomy devices market report analyzes the micromarkets with respect to their individual growth trends, prospects, and contributions to the thrombectomy devices market.
Reasons to buy the report:
From an insights perspective, this research report is focused on various levels of analysis—industry trends and company profiles—which together discuss basic views on the competitive landscape, emerging and high growth segments of the thrombectomy devices market, and high growth regions and their respective drivers, restraints, opportunities, and challenges.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and in turn help firms garner greater shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
In this report, the market has been segmented on the basis of type, application, end user, and region. Based on application, the cardiovascular segment commanded the largest share of the global thrombectomy devices market in 2016. This large market share is mainly attributed to factors such as increasing prevalence of cardiovascular diseases across major markets, procedural benefits offered by mechanical thrombectomy in cardiac surgeries, higher prevalence of thrombotic diseases among geriatric individuals, and growing preference of surgeons for image-guided and minimally invasive cardiac surgeries.
Geographically, North America is estimated to command the largest share of the global thrombectomy devices market in 2016, followed by Europe. This large market share of the North American region can be attributed to increasing adoption of technologically advanced thrombectomy products, growing number of clinical trials, and significant medical reimbursement available in the U.S. for thrombectomy procedures.
Report Coverage:
This report studies global thrombectomy devices market based on type, application, and end user. The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the thrombectomy devices market report analyzes the micromarkets with respect to their individual growth trends, prospects, and contributions to the thrombectomy devices market.
Reasons to buy the report:
From an insights perspective, this research report is focused on various levels of analysis—industry trends and company profiles—which together discuss basic views on the competitive landscape, emerging and high growth segments of the thrombectomy devices market, and high growth regions and their respective drivers, restraints, opportunities, and challenges.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and in turn help firms garner greater shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the major players in the thrombectomy devices market. The report analyzes the market based on type, application, end user, and region.
- Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the thrombectomy devices market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various thrombectomy devices across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the thrombectomy devices market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the thrombectomy devices market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.2 OPPORTUNITY INDICATORS
2.2.1.1 Rising geriatric population
2.2.1.2 Number of hospitals and surgical centers
2.2.1.3 Increased prevalence of cardiovascular diseases
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 THROMBECTOMY SYSTEM: MARKET SNAPSHOT (2017-2022)
4.2 REGIONAL ANALYSIS: THROMBECTOMY SYSTEM MARKET, BY APPLICATION (2016)
4.3 REGIONAL ANALYSIS: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE
(2017 VS. 2022)
4.4 REGIONAL ANALYSIS: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER
(2017 VS. 2022)
4.5 GEOGRAPHIC ANALYSIS: THROMBECTOMY SYSTEM MARKET, BY COUNTRY
(2017-2022)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 KEY MARKET DRIVERS
5.2.1.1 Growing target patient population
5.2.1.2 Ongoing technological advancements
5.2.1.3 Favorable medical reimbursement scenario
5.2.1.4 Increasing healthcare expenditure across emerging markets
5.2.1.5 Rising demand for minimally invasive thrombectomy procedures
5.2.2 KEY MARKET RESTRAINTS
5.2.2.1 Stringent regulatory scenario
5.2.2.2 Limited patient awareness related to thrombectomy resulting in delayed treatment for peripheral vascular diseases
5.2.3 KEY MARKET OPPORTUNITIES
5.2.3.1 Increasing number of research activities in the field of thrombectomy
5.2.3.2 Expanding application of ultrasound in vascular treatment
5.2.4 KEY MARKET CHALLENGES
5.2.4.1 Limited availability of clinical data to validate the therapeutic efficacy of clot retrieval devices
5.2.4.2 Dearth of skilled and well-trained surgeons
5.3 RESEARCH PIPELINE ANALYSIS
5.3.1 ASPIRATION THROMBECTOMY
5.3.2 MECHANICAL THROMBECTOMY
5.3.3 RHEOLYTIC THROMBECTOMY
5.3.4 ULTRASONIC THROMBECTOMY
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 SUPPLY CHAIN ANALYSIS
6.2.1 MAJOR STAKEHOLDERS
6.2.2 KEY INFLUENCERS
6.3 INDUSTRY TRENDS
6.3.1 GROWING ADOPTION OF LASER-ASSISTED THROMBECTOMY
6.4 PORTER’S FIVE FORCES ANALYSIS
6.5 CURRENT REIMBURSEMENT SCENARIO IN US AND GERMANY (AS OF DECEMBER 2016)
7 GLOBAL THROMBECTOMY SYSTEM MARKET, BY TYPE
7.1 INTRODUCTION
7.2 ASPIRATION THROMBECTOMY SYSTEM
7.3 MECHANICAL/FRAGMENTATION THROMBECTOMY SYSTEM
7.3.1 STENT RETRIEVERS
7.3.2 COIL RETRIEVERS
7.3.3 BASKET/BRUSH RETRIEVERS
7.4 RHEOLYTIC/HYDRODYNAMIC THROMBECTOMY SYSTEM
7.5 ULTRASONIC THROMBECTOMY SYSTEM
8 GLOBAL THROMBECTOMY SYSTEM MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 CARDIOVASCULAR APPLICATIONS
8.3 NEUROVASCULAR APPLICATIONS
8.4 PERIPHERAL VASCULAR APPLICATIONS
9 GLOBAL THROMBECTOMY SYSTEM MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS AND SURGICAL CENTERS
9.3 AMBULATORY SURGICAL CENTERS
9.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
9.5 OTHER END USERS
10 THROMBECTOMY SYSTEM MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 LATIN AMERICA
10.5.2 MIDDLE EAST AND AFRICA (MEA)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 VENDOR DIVE OVERVIEW
11.2.1 VANGUARDS
11.2.2 INNOVATORS
11.2.3 DYNAMIC
11.2.4 EMERGING
*Top 25 companies analyzed for this studies are - Stryker Corporation (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Terumo Corporation (Japan), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Teleflex Incorporated (U.S.), Argon Medical Devices, Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), Straub Medical Ag (Switzerland), BTG International (U.K.), Phenox GmbH (Germany), Acandis GmbH Co. & Kg (Germany), Merit Medical Systems, Inc. (U.S.), Minnetronix, Inc. (U.S.) NexGen Medical Systems, Inc. (U.S.), Capture Vascular (U.S.), Applied Medical (U.S.), Claret Medical (U.S.), Lemaitre Vascular (U.S.), Stentys (France), Dispomedical GmbH( Germany), Control Medical Tecyhnology (U.S.), and Natec Medical Ltd (Mauritius)
12 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION
12.1.1 GEOGRAPHIC BENCHMARKING
12.2 TOP MARKET PLAYERS
12.2.1 STRYKER CORPORATION
12.2.2 MEDTRONIC PLC
12.2.3 JOHNSON & JOHNSON
12.2.4 TERUMO CORPORATION
12.2.5 BOSTON SCIENTIFIC CORPORATION
12.2.6 SPECTRANETICS CORPORATION
12.2.7 PENUMBRA, INC.
12.2.8 ARGON MEDICAL DEVICES, INC.
12.2.9 EDWARDS LIFESCIENCES CORPORATION
12.2.10 TELEFLEX INCORPORATED
12.3 EMERGING PLAYERS
12.3.1 STRAUB MEDICAL AG
12.3.2 BTG INTERNATIONAL LTD.
12.3.3 PHENOX GMBH
12.3.4 ACANDIS GMBH & CO. KG
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 PRIMARY INSIGHTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.2 OPPORTUNITY INDICATORS
2.2.1.1 Rising geriatric population
2.2.1.2 Number of hospitals and surgical centers
2.2.1.3 Increased prevalence of cardiovascular diseases
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 THROMBECTOMY SYSTEM: MARKET SNAPSHOT (2017-2022)
4.2 REGIONAL ANALYSIS: THROMBECTOMY SYSTEM MARKET, BY APPLICATION (2016)
4.3 REGIONAL ANALYSIS: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE
(2017 VS. 2022)
4.4 REGIONAL ANALYSIS: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER
(2017 VS. 2022)
4.5 GEOGRAPHIC ANALYSIS: THROMBECTOMY SYSTEM MARKET, BY COUNTRY
(2017-2022)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 KEY MARKET DRIVERS
5.2.1.1 Growing target patient population
5.2.1.2 Ongoing technological advancements
5.2.1.3 Favorable medical reimbursement scenario
5.2.1.4 Increasing healthcare expenditure across emerging markets
5.2.1.5 Rising demand for minimally invasive thrombectomy procedures
5.2.2 KEY MARKET RESTRAINTS
5.2.2.1 Stringent regulatory scenario
5.2.2.2 Limited patient awareness related to thrombectomy resulting in delayed treatment for peripheral vascular diseases
5.2.3 KEY MARKET OPPORTUNITIES
5.2.3.1 Increasing number of research activities in the field of thrombectomy
5.2.3.2 Expanding application of ultrasound in vascular treatment
5.2.4 KEY MARKET CHALLENGES
5.2.4.1 Limited availability of clinical data to validate the therapeutic efficacy of clot retrieval devices
5.2.4.2 Dearth of skilled and well-trained surgeons
5.3 RESEARCH PIPELINE ANALYSIS
5.3.1 ASPIRATION THROMBECTOMY
5.3.2 MECHANICAL THROMBECTOMY
5.3.3 RHEOLYTIC THROMBECTOMY
5.3.4 ULTRASONIC THROMBECTOMY
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 SUPPLY CHAIN ANALYSIS
6.2.1 MAJOR STAKEHOLDERS
6.2.2 KEY INFLUENCERS
6.3 INDUSTRY TRENDS
6.3.1 GROWING ADOPTION OF LASER-ASSISTED THROMBECTOMY
6.4 PORTER’S FIVE FORCES ANALYSIS
6.5 CURRENT REIMBURSEMENT SCENARIO IN US AND GERMANY (AS OF DECEMBER 2016)
7 GLOBAL THROMBECTOMY SYSTEM MARKET, BY TYPE
7.1 INTRODUCTION
7.2 ASPIRATION THROMBECTOMY SYSTEM
7.3 MECHANICAL/FRAGMENTATION THROMBECTOMY SYSTEM
7.3.1 STENT RETRIEVERS
7.3.2 COIL RETRIEVERS
7.3.3 BASKET/BRUSH RETRIEVERS
7.4 RHEOLYTIC/HYDRODYNAMIC THROMBECTOMY SYSTEM
7.5 ULTRASONIC THROMBECTOMY SYSTEM
8 GLOBAL THROMBECTOMY SYSTEM MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 CARDIOVASCULAR APPLICATIONS
8.3 NEUROVASCULAR APPLICATIONS
8.4 PERIPHERAL VASCULAR APPLICATIONS
9 GLOBAL THROMBECTOMY SYSTEM MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS AND SURGICAL CENTERS
9.3 AMBULATORY SURGICAL CENTERS
9.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
9.5 OTHER END USERS
10 THROMBECTOMY SYSTEM MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 LATIN AMERICA
10.5.2 MIDDLE EAST AND AFRICA (MEA)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 VENDOR DIVE OVERVIEW
11.2.1 VANGUARDS
11.2.2 INNOVATORS
11.2.3 DYNAMIC
11.2.4 EMERGING
*Top 25 companies analyzed for this studies are - Stryker Corporation (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Terumo Corporation (Japan), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Teleflex Incorporated (U.S.), Argon Medical Devices, Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), Straub Medical Ag (Switzerland), BTG International (U.K.), Phenox GmbH (Germany), Acandis GmbH Co. & Kg (Germany), Merit Medical Systems, Inc. (U.S.), Minnetronix, Inc. (U.S.) NexGen Medical Systems, Inc. (U.S.), Capture Vascular (U.S.), Applied Medical (U.S.), Claret Medical (U.S.), Lemaitre Vascular (U.S.), Stentys (France), Dispomedical GmbH( Germany), Control Medical Tecyhnology (U.S.), and Natec Medical Ltd (Mauritius)
12 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION
12.1.1 GEOGRAPHIC BENCHMARKING
12.2 TOP MARKET PLAYERS
12.2.1 STRYKER CORPORATION
12.2.2 MEDTRONIC PLC
12.2.3 JOHNSON & JOHNSON
12.2.4 TERUMO CORPORATION
12.2.5 BOSTON SCIENTIFIC CORPORATION
12.2.6 SPECTRANETICS CORPORATION
12.2.7 PENUMBRA, INC.
12.2.8 ARGON MEDICAL DEVICES, INC.
12.2.9 EDWARDS LIFESCIENCES CORPORATION
12.2.10 TELEFLEX INCORPORATED
12.3 EMERGING PLAYERS
12.3.1 STRAUB MEDICAL AG
12.3.2 BTG INTERNATIONAL LTD.
12.3.3 PHENOX GMBH
12.3.4 ACANDIS GMBH & CO. KG
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 PRIMARY INSIGHTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 ASPIRATION THROMBECTOMY CATHETERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
Table 2 CLOT RETRIEVERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
Table 3 STENT RETRIEVERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
Table 4 RHEOLYTIC THROMBECTOMY DEVICES: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
Table 5 ULTRASONIC THROMBECTOMY DEVICES: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
Table 6 MEDICAL REIMBURSEMENTS FOR THROMBECTOMY PROCEDURES (AS OF DECEMBER 2016)
Table 7 GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 8 ASPIRATION THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 9 MECHANICAL/FRAGMENTATION THROMBECTOMY SYSTEM MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 10 MECHANICAL/FRAGMENTATION THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 11 STENT RETRIEVERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 12 COIL RETRIEVERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 13 BASKET/BRUSH RETRIEVERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 14 RHEOLYTIC/HYDRODYNAMIC THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 15 ULTRASONIC THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 16 GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 17 THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 18 THROMBECTOMY SYSTEM MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 19 THROMBECTOMY SYSTEM MARKET SIZE FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
Table 20 THROMBECTOMY SYSTEM MARKET SIZE FOR PERIPHERAL VASCULAR, BY REGION, 2015-2022 (USD MILLION)
Table 21 THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 22 THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 23 THROMBECTOMY SYSTEM MARKET SIZE FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2015–2022 (USD MILLION)
Table 24 THROMBECTOMY SYSTEM MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2015–2022 (USD MILLION)
Table 25 THROMBECTOMY SYSTEM MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2015–2022 (USD MILLION)
Table 26 THROMBECTOMY SYSTEM MARKET SIZE FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION)
Table 27 THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 28 NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 29 NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 30 NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 31 NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 32 U.S.: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 33 U.S.: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 34 CANADA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 35 CANADA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 36 EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 37 EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 38 EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 39 EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 40 GERMANY: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 41 GERMANY: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 42 FRANCE: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 43 FRANCE: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 44 U.K.: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 45 U.K.: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 46 ROE: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 47 ROE: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 48 ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 49 ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 50 ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 51 ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 52 JAPAN: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 53 JAPAN: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 54 CHINA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 55 CHINA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 56 INDIA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 57 INDIA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 58 ROAPAC: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 59 ROAPAC: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 60 ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 61 ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 62 ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 63 ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 64 LATIN AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 65 LATIN AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 66 MIDDLE EAST & AFRICA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 67 MIDDLE EAST & AFRICA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 1 ASPIRATION THROMBECTOMY CATHETERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
Table 2 CLOT RETRIEVERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
Table 3 STENT RETRIEVERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
Table 4 RHEOLYTIC THROMBECTOMY DEVICES: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
Table 5 ULTRASONIC THROMBECTOMY DEVICES: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
Table 6 MEDICAL REIMBURSEMENTS FOR THROMBECTOMY PROCEDURES (AS OF DECEMBER 2016)
Table 7 GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 8 ASPIRATION THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 9 MECHANICAL/FRAGMENTATION THROMBECTOMY SYSTEM MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 10 MECHANICAL/FRAGMENTATION THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 11 STENT RETRIEVERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 12 COIL RETRIEVERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 13 BASKET/BRUSH RETRIEVERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 14 RHEOLYTIC/HYDRODYNAMIC THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 15 ULTRASONIC THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 16 GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 17 THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 18 THROMBECTOMY SYSTEM MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 19 THROMBECTOMY SYSTEM MARKET SIZE FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
Table 20 THROMBECTOMY SYSTEM MARKET SIZE FOR PERIPHERAL VASCULAR, BY REGION, 2015-2022 (USD MILLION)
Table 21 THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 22 THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 23 THROMBECTOMY SYSTEM MARKET SIZE FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2015–2022 (USD MILLION)
Table 24 THROMBECTOMY SYSTEM MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2015–2022 (USD MILLION)
Table 25 THROMBECTOMY SYSTEM MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2015–2022 (USD MILLION)
Table 26 THROMBECTOMY SYSTEM MARKET SIZE FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION)
Table 27 THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 28 NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 29 NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 30 NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 31 NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 32 U.S.: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 33 U.S.: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 34 CANADA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 35 CANADA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 36 EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 37 EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 38 EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 39 EUROPE: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 40 GERMANY: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 41 GERMANY: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 42 FRANCE: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 43 FRANCE: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 44 U.K.: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 45 U.K.: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 46 ROE: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 47 ROE: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 48 ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 49 ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 50 ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 51 ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 52 JAPAN: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 53 JAPAN: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 54 CHINA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 55 CHINA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 56 INDIA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 57 INDIA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 58 ROAPAC: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 59 ROAPAC: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 60 ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 61 ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 62 ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 63 ROW: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 64 LATIN AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 65 LATIN AMERICA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 66 MIDDLE EAST & AFRICA: THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
Table 67 MIDDLE EAST & AFRICA: THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 BREAKDOWN OF PRIMARIES
Figure 3 INCREASE IN GERIATRIC POPULATION: BY COUNTRY (2010 VS. 2015)
Figure 4 INCREASE IN THE PROPORTION OF GERIATRIC INDIVIDUALS IN THE OVERALL POPULATION: BY COUNTRY (2011 VS. 2015 VS. 2030)
Figure 5 PERCENTAGE INCREASE IN GERIATRIC POPULATION, BY REGION (1980-2010 VS. 2010–2040)
Figure 6 BOTTOM-UP APPROACH
Figure 7 TOP-DOWN APPROACH
Figure 8 DATA TRIANGULATION
Figure 9 GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2017 VS. 2022
Figure 10 GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2017 VS. 2022
Figure 11 GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2017 VS. 2022
Figure 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL THROMBECTOMY SYSTEM MARKET
Figure 13 GROWING TARGET PATIENT POPULATION TO PROPEL THE DEMAND FOR THROMBECTOMY SYSTEM DURING THE FORECAST PERIOD
Figure 14 NORTH AMERICA DOMINATED THE THROMBECTOMY SYSTEM MARKET FOR ALL APPLICATION SEGMENTS IN 2016
Figure 15 MECHANICAL THROMBECTOMY SYSTEM SEGMENT WILL CONTINUE TO DOMINATE THE THROMBECTOMY SYSTEM MARKET ACROSS ALL REGIONS IN 2022
Figure 16 HOSPITALS & SURGICAL CENTERS WILL DOMINATE THE THROMBECTOMY SYSTEM MARKET ACROSS ALL REGIONS IN 2017
Figure 17 CHINA & INDIA ESTIMATED TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL THROMBECTOMY SYSTEM MARKET
Figure 18 THROMBECTOMY SYSTEM MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 19 PROPORTION OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, (2012 VS. 2020)
Figure 20 GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING COUNTRIES (2010–2015)
Figure 21 ONGOING CLINICAL TRIALS ACROSS THE GLOBE (AS OF DECEMBER 2016)
Figure 22 SUPPLY CHAIN ANALYSIS: THROMBECTOMY SYSTEM INDUSTRY
Figure 23 PORTER’S FIVE FORCES ANALYSIS (2016)
Figure 24 MECHANICAL THROMBECTOMY SYSTEM SEGMENT TO WITNESS HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
Figure 25 STENT RETRIEVERS SEGMENT TO DOMINATE THE MECHANICAL THROMBECTOMY MARKET DURING THE FORECAST PERIOD
Figure 26 NORTH AMERICA TO HOLD LARGEST SHARE OF THE ULTRASONIC THROMBECTOMY SYSTEM MARKET DURING THE FORECAST PERIOD
Figure 27 CARDIOVASCULAR APPLICATIONS TO DOMINATE THE THROMBECTOMY SYSTEM MARKET DURING THE FORECAST PERIOD
Figure 28 NORTH AMERICA TO HOLD LARGEST SHARE OF THE PERIPHERAL VASCULAR APPLICATION MARKET DURING THE FORECAST PERIOD
Figure 29 HOSPITALS & SURGICAL CENTERS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 30 NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SNAPSHOT
Figure 31 EUROPE: THROMBECTOMY SYSTEM MARKET SNAPSHOT
Figure 32 ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SNAPSHOT
Figure 33 ROW: THROMBECTOMY SYSTEM MARKET SNAPSHOT
Figure 34 MNM DIVE – VENDOR COMPARISON MATRIX : THROMBECTOMY SYSTEM MARKET
Figure 35 ANALYSIS OF PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE THROMBECTOMY SYSTEM MARKET (25 PLAYERS)
Figure 36 BUSINESS STRATEGY ADOPTED BY MAJOR PLAYERS IN THE THROMBECTOMY SYSTEM MARKET (25 PLAYERS)
Figure 37 GEOGRAPHIC REVENUE MIX OF THE TOP FOUR MARKET PLAYERS (AS OF 2016)
Figure 38 STRYKER CORPORATION: COMPANY SNAPSHOT (2016)
Figure 39 STRYKER CORPORATION: PRODUCT OFFERING SCORECARD
Figure 40 STRYKER CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 41 MEDTRONIC PLC: COMPANY SNAPSHOT (2016)
Figure 42 MEDTRONIC PLC: PRODUCT OFFERING SCORECARD
Figure 43 MEDTRONIC PLC: BUSINESS STRATEGY SCORECARD
Figure 44 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2015)
Figure 45 JOHNSON & JOHNSON: PRODUCT OFFERING SCORECARD
Figure 46 JOHNSON & JOHNSON: BUSINESS STRATEGY SCORECARD
Figure 47 TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
Figure 48 TERUMO CORPORATION: PRODUCT OFFERING SCORECARD
Figure 49 TERUMO CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2016)
Figure 51 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD
Figure 52 BOSTON SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 53 SPECTRANETICS CORPORATION: COMPANY SNAPSHOT (2016)
Figure 54 SPECTRANETICS CORPORATION: PRODUCT OFFERING SCORECARD
Figure 55 SPECTRANETICS CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 56 PENUMBRA, INC.: COMPANY SNAPSHOT (2016)
Figure 57 PENUMBRA, INC.: PRODUCT OFFERING SCORECARD
Figure 58 PENUMBRA, INC.: BUSINESS STRATEGY SCORECARD
Figure 59 ARGON MEDICAL DEVICES, INC.: PRODUCT OFFERING SCORECARD
Figure 60 ARGON MEDICAL DEVICES, INC.: BUSINESS STRATEGY SCORECARD
Figure 61 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2016)
Figure 62 EDWARDS LIFESCIENCES CORPORATION: PRODUCT OFFERING SCORECARD
Figure 63 EDWARDS LIFESCIENCES CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 64 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2016)
Figure 65 TELEFLEX INCORPORATED: PRODUCT OFFERING SCORECARD
Figure 66 TELEFLEX INCORPORATED: BUSINESS STRATEGY SCORECARD
Figure 67 STRAUB MEDICAL AG: PRODUCT OFFERING SCORECARD
Figure 68 STRAUB MEDICAL AG: BUSINESS STRATEGY SCORECARD
Figure 69 BTG INTERNATIONAL LTD.: COMPANY SNAPSHOT (2016)
Figure 70 BTG INTERNATIONAL LTD.: PRODUCT OFFERING SCORECARD
Figure 71 BTG INTERNATIONAL LTD.: BUSINESS STRATEGY SCORECARD
Figure 72 PHENOX GMBH: PRODUCT OFFERING SCORECARD
Figure 73 PHENOX GMBH: BUSINESS STRATEGY SCORECARD
Figure 74 ACANDIS GMBH: PRODUCT OFFERING SCORECARD
Figure 75 ACANDIS GMBH: BUSINESS STRATEGY SCORECARD
Figure 1 RESEARCH DESIGN
Figure 2 BREAKDOWN OF PRIMARIES
Figure 3 INCREASE IN GERIATRIC POPULATION: BY COUNTRY (2010 VS. 2015)
Figure 4 INCREASE IN THE PROPORTION OF GERIATRIC INDIVIDUALS IN THE OVERALL POPULATION: BY COUNTRY (2011 VS. 2015 VS. 2030)
Figure 5 PERCENTAGE INCREASE IN GERIATRIC POPULATION, BY REGION (1980-2010 VS. 2010–2040)
Figure 6 BOTTOM-UP APPROACH
Figure 7 TOP-DOWN APPROACH
Figure 8 DATA TRIANGULATION
Figure 9 GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2017 VS. 2022
Figure 10 GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2017 VS. 2022
Figure 11 GLOBAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USER, 2017 VS. 2022
Figure 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL THROMBECTOMY SYSTEM MARKET
Figure 13 GROWING TARGET PATIENT POPULATION TO PROPEL THE DEMAND FOR THROMBECTOMY SYSTEM DURING THE FORECAST PERIOD
Figure 14 NORTH AMERICA DOMINATED THE THROMBECTOMY SYSTEM MARKET FOR ALL APPLICATION SEGMENTS IN 2016
Figure 15 MECHANICAL THROMBECTOMY SYSTEM SEGMENT WILL CONTINUE TO DOMINATE THE THROMBECTOMY SYSTEM MARKET ACROSS ALL REGIONS IN 2022
Figure 16 HOSPITALS & SURGICAL CENTERS WILL DOMINATE THE THROMBECTOMY SYSTEM MARKET ACROSS ALL REGIONS IN 2017
Figure 17 CHINA & INDIA ESTIMATED TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL THROMBECTOMY SYSTEM MARKET
Figure 18 THROMBECTOMY SYSTEM MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 19 PROPORTION OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, (2012 VS. 2020)
Figure 20 GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING COUNTRIES (2010–2015)
Figure 21 ONGOING CLINICAL TRIALS ACROSS THE GLOBE (AS OF DECEMBER 2016)
Figure 22 SUPPLY CHAIN ANALYSIS: THROMBECTOMY SYSTEM INDUSTRY
Figure 23 PORTER’S FIVE FORCES ANALYSIS (2016)
Figure 24 MECHANICAL THROMBECTOMY SYSTEM SEGMENT TO WITNESS HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
Figure 25 STENT RETRIEVERS SEGMENT TO DOMINATE THE MECHANICAL THROMBECTOMY MARKET DURING THE FORECAST PERIOD
Figure 26 NORTH AMERICA TO HOLD LARGEST SHARE OF THE ULTRASONIC THROMBECTOMY SYSTEM MARKET DURING THE FORECAST PERIOD
Figure 27 CARDIOVASCULAR APPLICATIONS TO DOMINATE THE THROMBECTOMY SYSTEM MARKET DURING THE FORECAST PERIOD
Figure 28 NORTH AMERICA TO HOLD LARGEST SHARE OF THE PERIPHERAL VASCULAR APPLICATION MARKET DURING THE FORECAST PERIOD
Figure 29 HOSPITALS & SURGICAL CENTERS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 30 NORTH AMERICA: THROMBECTOMY SYSTEM MARKET SNAPSHOT
Figure 31 EUROPE: THROMBECTOMY SYSTEM MARKET SNAPSHOT
Figure 32 ASIA-PACIFIC: THROMBECTOMY SYSTEM MARKET SNAPSHOT
Figure 33 ROW: THROMBECTOMY SYSTEM MARKET SNAPSHOT
Figure 34 MNM DIVE – VENDOR COMPARISON MATRIX : THROMBECTOMY SYSTEM MARKET
Figure 35 ANALYSIS OF PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE THROMBECTOMY SYSTEM MARKET (25 PLAYERS)
Figure 36 BUSINESS STRATEGY ADOPTED BY MAJOR PLAYERS IN THE THROMBECTOMY SYSTEM MARKET (25 PLAYERS)
Figure 37 GEOGRAPHIC REVENUE MIX OF THE TOP FOUR MARKET PLAYERS (AS OF 2016)
Figure 38 STRYKER CORPORATION: COMPANY SNAPSHOT (2016)
Figure 39 STRYKER CORPORATION: PRODUCT OFFERING SCORECARD
Figure 40 STRYKER CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 41 MEDTRONIC PLC: COMPANY SNAPSHOT (2016)
Figure 42 MEDTRONIC PLC: PRODUCT OFFERING SCORECARD
Figure 43 MEDTRONIC PLC: BUSINESS STRATEGY SCORECARD
Figure 44 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2015)
Figure 45 JOHNSON & JOHNSON: PRODUCT OFFERING SCORECARD
Figure 46 JOHNSON & JOHNSON: BUSINESS STRATEGY SCORECARD
Figure 47 TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
Figure 48 TERUMO CORPORATION: PRODUCT OFFERING SCORECARD
Figure 49 TERUMO CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2016)
Figure 51 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD
Figure 52 BOSTON SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 53 SPECTRANETICS CORPORATION: COMPANY SNAPSHOT (2016)
Figure 54 SPECTRANETICS CORPORATION: PRODUCT OFFERING SCORECARD
Figure 55 SPECTRANETICS CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 56 PENUMBRA, INC.: COMPANY SNAPSHOT (2016)
Figure 57 PENUMBRA, INC.: PRODUCT OFFERING SCORECARD
Figure 58 PENUMBRA, INC.: BUSINESS STRATEGY SCORECARD
Figure 59 ARGON MEDICAL DEVICES, INC.: PRODUCT OFFERING SCORECARD
Figure 60 ARGON MEDICAL DEVICES, INC.: BUSINESS STRATEGY SCORECARD
Figure 61 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2016)
Figure 62 EDWARDS LIFESCIENCES CORPORATION: PRODUCT OFFERING SCORECARD
Figure 63 EDWARDS LIFESCIENCES CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 64 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2016)
Figure 65 TELEFLEX INCORPORATED: PRODUCT OFFERING SCORECARD
Figure 66 TELEFLEX INCORPORATED: BUSINESS STRATEGY SCORECARD
Figure 67 STRAUB MEDICAL AG: PRODUCT OFFERING SCORECARD
Figure 68 STRAUB MEDICAL AG: BUSINESS STRATEGY SCORECARD
Figure 69 BTG INTERNATIONAL LTD.: COMPANY SNAPSHOT (2016)
Figure 70 BTG INTERNATIONAL LTD.: PRODUCT OFFERING SCORECARD
Figure 71 BTG INTERNATIONAL LTD.: BUSINESS STRATEGY SCORECARD
Figure 72 PHENOX GMBH: PRODUCT OFFERING SCORECARD
Figure 73 PHENOX GMBH: BUSINESS STRATEGY SCORECARD
Figure 74 ACANDIS GMBH: PRODUCT OFFERING SCORECARD
Figure 75 ACANDIS GMBH: BUSINESS STRATEGY SCORECARD
